BioPharma
22 June, 2026 | Monday | Analysis
After the Drug Substance, the Real Squeeze: APAC's Aseptic Fill-Finish Gap
For most of the last decade, the anxiety in Asia-Pacific biomanufacturing pointed upstream. The conversation was about bioreactor volume — how many thousands of litres a campus could install, how fast a C...
Lab
16 June, 2026 | Tuesday | News
QIAGEN Bets Big on Digital PCR with Major QIAcuity Ecosystem Expansion
Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas Expanded Cell and Gene Therapy offerin...
BioTech
19 June, 2026 | Friday | Analysis
Billions on Bioconjugation: Is APAC Building the Right ADC Capacity — or Too Much?
In Songdo, on the reclaimed waterfront west of Seoul, a 202,000-square-metre construction site is becoming the most expensive single statement Korea's biopharma sector has made about its future. Lotte B...
Contract Services
22 June, 2026 | Monday | News
Avance Clinical Expands APAC And China Operations To Accelerate Global Biotech Trials
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, announced a significant expansion of its Asia Pacific and China operations, reinforcing its position as th...
Consumer Health
10 June, 2026 | Wednesday | News
AI Must Shift Healthcare From Crisis Response To Early Intervention Across APAC
As healthcare systems across Asia Pacific confront mounting workforce shortages, ageing populations, and rising chronic disease burdens, artificial intelligence is emerging as a critical enabler of more efficie...
Medtech
22 June, 2026 | Monday | News
HaemaLogiX Secures Ethics Approval For Phase 2b KappaMab Clinical Trial In Relapsed Multiple Myeloma
Ethics approval received from the Alfred Hospital Human Research Ethics Committee (Bayside Health) for Phase 2b KappaMab™ clinical trial “HLX-KM-04” Study will evaluate safety and efficacy ...
Cell & Gene
16 June, 2026 | Tuesday | News
QIAGEN Bets Big on Digital PCR with Major QIAcuity Ecosystem Expansion
Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas Expanded Cell and Gene Therapy offerin...
White Paper
22 June, 2026 | Monday | Analysis
After the Drug Substance, the Real Squeeze: APAC's Aseptic Fill-Finish Gap
Product Spot Light
Premium Article
22 June, 2026 | Monday | Analysis
After the Drug Substance, the Real Squeeze: APAC's Aseptic Fill-Finish Gap
Bio Invest
15 June, 2026 | Monday | News
Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
